Neurogen Announces Phase I Clinical Trial For Proprietary Obesity Drug
14th Nov 2006, 13:31 GMT
Neurogen Corporation (Nasdaq: NRGN) today announced that it has commenced Phase I human testing of the Company's leading drug candidate for treatment of obesity. The compound, NGD-4715, works as an antagonist at the melanin concentrating hormone receptor-1 (MCH1). NGD-4715 and other compounds in the Company's obesity program are wholly-owned by Neurogen. William H. [click link for full article]
Neurogen Announces Phase I Clinical Trial For Proprietary Obesity Drug related news:
- Neurogen's obesity drug in phase 1 trial — United Press International - Health Business
- Neurogen commences human testing of obesity drug — Pharmaceutical Business Review Latest News
- Human Genome Sciences Announces Positive 76-Week Results of Phase 2 Clinical Trial of LymphoStat-B(TM) in Systemic Lupus Erythematosus — PR Newswire: All Releases
- Favrille Announces Interim Analysis of Secondary Endpoint from Pivotal Phase 3 Clinical Trial of FavId Following Rituxan in Follicular B-Cell Non-Hodgkin's Lymphoma — Bio-Technology News from StratCenter.com
- Lilly drug reduces blindness in diabetic patients — Pharmaceutical Business Review Latest News
- Favrille Announces Interim Analysis Of Secondary Endpoint From Pivotal Phase 3 Clinical Trial Of FavId Following Rituxan — Health News from Medical News Today
- Isis Pharma's shares soar on cholesterol-drug Phase II data — MarketWatch.com - Top Stories – Sponsored by: CyberTrader
- Study Findings Challenge Current Clinical Practice Clinical Trial Results Find Late Angioplasty after Heart Attack Offers No Advantage Over Standard Drug Therapy — National Institutes of Health (NIH) News Releases
- Scientists Design A PSA-activated Protoxin That Kills Prostate Cancer: Phase I Clinical Trial Is Under Way — Health News from Medical News Today
- ZymoGenetics and Serono Report Detailed Positive Results From Atacicept Phase 1b Clinical Trial in Patients With Lupus — PR Newswire: All Releases
Latest news from Health News from Medical News Today:
- Biotech Industry Welcomes WHO Initiative On Naming Of Biologicals Including Biosimilar Medicines
- Common Cause Of Heart Disease, Diabetes May Be Treatable With Malaria Drug
- Two Nerve Cells In Direct Contact
- Value Of 'Helper' Compound In Treating Some Leukemias
- Internists Take Home Several National Awards At AAMC Annual Meeting
- Most Canadian Med School Grads Lack Basic Surgical Skills
- ACP's Electronic Medical Resource Ranked No. 1 Evidence-based Tool By MLA's South Central Chapter
- University Of Illinois Scientist Helping Processors Keep E. Coli Out Of Meat
- American Thoracic Society Publishes New Statement On Hepatotoxicity Of Antituberculosis Therapy
- Neural Networking Nanotubes